494 related articles for article (PubMed ID: 25875452)
1. Production of α2,6-sialylated IgG1 in CHO cells.
Raymond C; Robotham A; Spearman M; Butler M; Kelly J; Durocher Y
MAbs; 2015; 7(3):571-83. PubMed ID: 25875452
[TBL] [Abstract][Full Text] [Related]
2. Enhanced sialylation of recombinant erythropoietin in CHO cells by human glycosyltransferase expression.
Jeong YT; Choi O; Lim HR; Son YD; Kim HJ; Kim JH
J Microbiol Biotechnol; 2008 Dec; 18(12):1945-52. PubMed ID: 19131698
[TBL] [Abstract][Full Text] [Related]
3. Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression.
Lin N; Mascarenhas J; Sealover NR; George HJ; Brooks J; Kayser KJ; Gau B; Yasa I; Azadi P; Archer-Hartmann S
Biotechnol Prog; 2015; 31(2):334-46. PubMed ID: 25641927
[TBL] [Abstract][Full Text] [Related]
4. Enhanced sialylation of a human chimeric IgG1 variant produced in human and rodent cell lines.
Mimura Y; Kelly RM; Unwin L; Albrecht S; Jefferis R; Goodall M; Mizukami Y; Mimura-Kimura Y; Matsumoto T; Ueoka H; Rudd PM
J Immunol Methods; 2016 Jan; 428():30-6. PubMed ID: 26627984
[TBL] [Abstract][Full Text] [Related]
5. Integrated Genome and Protein Editing Swaps α-2,6 Sialylation for α-2,3 Sialic Acid on Recombinant Antibodies from CHO.
Chung CY; Wang Q; Yang S; Yin B; Zhang H; Betenbaugh M
Biotechnol J; 2017 Feb; 12(2):. PubMed ID: 27943633
[TBL] [Abstract][Full Text] [Related]
6. Impact of Fc N-glycan sialylation on IgG structure.
Zhang Z; Shah B; Richardson J
MAbs; 2019; 11(8):1381-1390. PubMed ID: 31411531
[TBL] [Abstract][Full Text] [Related]
7. Enhanced sialylation of recombinant human erythropoietin in Chinese hamster ovary cells by combinatorial engineering of selected genes.
Son YD; Jeong YT; Park SY; Kim JH
Glycobiology; 2011 Aug; 21(8):1019-28. PubMed ID: 21436238
[TBL] [Abstract][Full Text] [Related]
8. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometric analysis of products of metabolic glycan engineering with azido-modification of sialic acids.
Bodnar E; Raymond C; Lopez PG; Villacrés C; Butler M; Schoenhofen IC; Durocher Y; Perreault H
Anal Bioanal Chem; 2015 Dec; 407(30):8945-58. PubMed ID: 26362153
[TBL] [Abstract][Full Text] [Related]
10. Sialylation of human IgG-Fc carbohydrate by transfected rat alpha2,6-sialyltransferase.
Jassal R; Jenkins N; Charlwood J; Camilleri P; Jefferis R; Lund J
Biochem Biophys Res Commun; 2001 Aug; 286(2):243-9. PubMed ID: 11500028
[TBL] [Abstract][Full Text] [Related]
11. The interplay of protein engineering and glycoengineering to fine-tune antibody glycosylation and its impact on effector functions.
Wang Q; Wang T; Zhang R; Yang S; McFarland KS; Chung CY; Jia H; Wang LX; Cipollo JF; Betenbaugh MJ
Biotechnol Bioeng; 2022 Jan; 119(1):102-117. PubMed ID: 34647616
[TBL] [Abstract][Full Text] [Related]
12. Ammonium alters N-glycan structures of recombinant TNFR-IgG: degradative versus biosynthetic mechanisms.
Gawlitzek M; Ryll T; Lofgren J; Sliwkowski MB
Biotechnol Bioeng; 2000 Jun; 68(6):637-46. PubMed ID: 10799988
[TBL] [Abstract][Full Text] [Related]
13. Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation.
Yin B; Gao Y; Chung CY; Yang S; Blake E; Stuczynski MC; Tang J; Kildegaard HF; Andersen MR; Zhang H; Betenbaugh MJ
Biotechnol Bioeng; 2015 Nov; 112(11):2343-51. PubMed ID: 26154505
[TBL] [Abstract][Full Text] [Related]
14. Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression.
Avril T; North SJ; Haslam SM; Willison HJ; Crocker PR
J Leukoc Biol; 2006 Oct; 80(4):787-96. PubMed ID: 16857734
[TBL] [Abstract][Full Text] [Related]
15. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles--part 1: separation-based methods.
Reusch D; Haberger M; Maier B; Maier M; Kloseck R; Zimmermann B; Hook M; Szabo Z; Tep S; Wegstein J; Alt N; Bulau P; Wuhrer M
MAbs; 2015; 7(1):167-79. PubMed ID: 25524468
[TBL] [Abstract][Full Text] [Related]
16. In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity.
Thomann M; Schlothauer T; Dashivets T; Malik S; Avenal C; Bulau P; Rüger P; Reusch D
PLoS One; 2015; 10(8):e0134949. PubMed ID: 26266936
[TBL] [Abstract][Full Text] [Related]
17. Linkage-specific action of endogenous sialic acid O-acetyltransferase in Chinese hamster ovary cells.
Shi WX; Chammas R; Varki A
J Biol Chem; 1996 Jun; 271(25):15130-8. PubMed ID: 8662976
[TBL] [Abstract][Full Text] [Related]
18. Enhanced sialylation of recombinant erythropoietin in genetically engineered Chinese-hamster ovary cells.
Jeong YT; Choi O; Son YD; Park SY; Kim JH
Biotechnol Appl Biochem; 2009 Apr; 52(Pt 4):283-91. PubMed ID: 18590515
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of glycosylation by stable co-expression of two sialylation-related enzymes on Chinese hamster ovary cells.
Thi Sam N; Misaki R; Ohashi T; Fujiyama K
J Biosci Bioeng; 2018 Jul; 126(1):102-110. PubMed ID: 29439861
[TBL] [Abstract][Full Text] [Related]
20. A sialylated glycan microarray reveals novel interactions of modified sialic acids with proteins and viruses.
Song X; Yu H; Chen X; Lasanajak Y; Tappert MM; Air GM; Tiwari VK; Cao H; Chokhawala HA; Zheng H; Cummings RD; Smith DF
J Biol Chem; 2011 Sep; 286(36):31610-22. PubMed ID: 21757734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]